nan
Artificial Intelligence-Powered Supplier Risk Management Market Size, Value And Growth Trends Through 2030
The revascularization device market size has demonstrated strong growth in recent years. It is expected to expand from $3.88 billion in 2025 to $4.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. This historical growth can be attributed to several factors, including the rising prevalence of coronary artery disease, a globally expanding aging population, the increasing expansion of catheterization laboratories, greater adoption of drug eluting stents, and advancements in interventional cardiology techniques.
The revascularization device market is anticipated to experience substantial expansion over the coming years. By 2030, its size is projected to reach $6.1 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period can be attributed to several factors, including the rise in precision-guided vascular interventions, a growing need for minimally invasive surgical procedures, the incorporation of AI-assisted interventional imaging, an increase in ambulatory surgical centers, and a heightened emphasis on bioresorbable and next-generation stents. Key trends anticipated during this period encompass the broadening of minimally invasive revascularization procedures, the uptake of bioresorbable scaffolds in vascular repair, sophisticated imaging-guided vascular interventions, an increase in radial access-based cardiovascular procedures, and a movement towards outpatient ambulatory vascular treatment.
Download A Free Sample Report For Comprehensive Market Insights:
Revascularization Device Market Expansion Supported By Key Demand Factors
The anticipated expansion of the revascularization device market is linked to the increasing occurrence of cardiovascular diseases. These diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, stroke, heart failure, and hypertension. The heightened incidence of CVDs largely stems from unhealthy living habits, which detrimentally affect cardiac health and elevate the likelihood of developing heart-related ailments. Revascularization devices play a role in managing cardiovascular diseases by enhancing and re-establishing blood circulation through obstructed or constricted arteries, which in turn diminishes ischemia and averts severe issues like heart attack and stroke. For example, data from March 2025, provided by the Joint Strategic Needs Assessment, a UK-based community health center, indicated that cardiovascular disease (CVD) led to 185 deaths in 2023, an increase from 178 deaths documented in 2022. Consequently, the expanding prevalence of cardiovascular diseases is a key factor propelling the expansion of the revascularization device market.
Artificial Intelligence-Powered Supplier Risk Management Market Segment Analysis And Revenue Opportunities
The revascularization device market covered in this report is segmented –
1) By Product Type: Atherectomy Devices; Balloon Angioplasty Catheters; Bare Metal Stents; Drug Coated Balloons; Drug Eluting Stents; Everolimus Eluting Stents
2) By Material Type: Bioabsorbable Scaffold; Metallic; Cobalt Chromium; Platinum Chromium; Stainless Steel; Polymer
3) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Renal Artery Interventions
4) By End User: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Specialty Cardiovascular Clinics; Research And Academic Institutes
Subsegments:
1) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
2) By Balloon Angioplasty Catheters: Semi Compliant Balloon Catheters; Non Compliant Balloon Catheters; Cutting Balloon Catheters; Scoring Balloon Catheters
3) By Bare Metal Stents: Cobalt Chromium Bare Metal Stents; Stainless Steel Bare Metal Stents; Nitinol Bare Metal Stents; Self Expanding Bare Metal Stents; Balloon Expandable Bare Metal Stents
4) By Drug Coated Balloons: Paclitaxel Coated Balloons; Sirolimus Coated Balloons; Dual Drug Coated Balloons; Polymer Based Drug Coated Balloons; Non Polymer Drug Coated Balloons
5) By Drug Eluting Stents: First Generation Drug Eluting Stents; Second Generation Drug Eluting Stents; Polymer Based Drug Eluting Stents; Biodegradable Polymer Drug Eluting Stents; Polymer Free Drug Eluting Stents
6) By Everolimus Eluting Stents: Durable Polymer Everolimus Eluting Stents; Polymer Free Everolimus Eluting Stents; Bioresorbable Scaffold Everolimus Eluting Stents; Thin Strut Everolimus Eluting Stents
Advancements In Next-Generation Intermediate Catheters Enhancing Clot Retrieval Efficiency And Stroke Intervention Outcomes
Major companies operating in the revascularization device market are focusing on developing innovative products, such as next-generation intermediate catheters to enhance blood vessel access, improve clot retrieval efficiency, and increase procedural success rates in minimally invasive stroke interventions. Intermediate catheters are flexible, large-lumen medical devices used during endovascular procedures to navigate cerebral and peripheral vasculature, facilitate aspiration or delivery of treatment devices, and support rapid revascularization in patients experiencing acute ischemic stroke. For instance, in February 2024, Cerenovus Inc., a US-based neurovascular company, launched the Cereglide 71 Intermediate Catheter designed for revascularization in patients with acute ischemic stroke. The device features a large inner lumen to support efficient clot removal, enhanced flexibility for navigation through tortuous vessels, and optimized wall construction to balance support and deliverability. It is intended to improve procedural efficiency in mechanical thrombectomy procedures and support faster reperfusion outcomes in time-critical stroke care scenarios.
Revascularization Device Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the revascularization device market are Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Becton Dickinson and Company; Stryker Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical LLC; Teleflex Incorporated; Asahi Intec Co. Ltd.; MicroPort Scientific Corporation; Biotronik SE & Co. KG; Penumbra Inc.; Lepu Medical Technology Co Ltd.; Merit Medical Systems Inc.; AngioDynamics Inc.; Cordis Corporation; MicroVention Inc.; OrbusNeich Medical Company Limited; Meril Life Sciences Pvt. Ltd.; Acotec Scientific Holdings Limited; Zylox-Tonbridge Medical Technology Co Ltd.; iVascular S.L.U.
Access The Complete Revascularization Device Market Report:
Revascularization Device Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the revascularization device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the revascularization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.